Holdings (as at 2026-03-03)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.95%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-03-03)
Security Name % of Net Assets
Moderna, Inc. 5.16%
Gilead Sciences, Inc. 4.33%
Amgen Inc. 4.10%
United Therapeutics Corporation 3.66%
Vertex Pharmaceuticals Incorporated 3.63%
Exact Sciences Corporation 3.59%
BioNTech SE (ADR) 3.58%
Krystal Biotech, Inc. 3.58%
BioMarin Pharmaceutical Inc. 3.52%
Alkermes Plc 3.49%
Biogen Inc. 3.48%
Neurocrine Biosciences, Inc. 3.43%
Regeneron Pharmaceuticals, Inc. 3.42%
Halozyme Therapeutics, Inc. 3.40%
argenx SE (ADR) 3.37%
Corcept Therapeutics Inc. 3.34%
Exelixis, Inc. 3.28%
Illumina, Inc. 3.26%
Incyte Corporation 3.26%
Natera, Inc. 3.14%
BeOne Medicines Ltd. (ADR) 3.12%
Bio-Techne Corporation 3.08%
ACADIA Pharmaceuticals Inc. 2.98%
Veracyte, Inc. 2.96%
Genmab A/S (ADR) 2.87%
Alnylam Pharmaceuticals, Inc. 2.84%
Repligen Corporation 2.62%
NeoGenomics, Inc. 2.57%
Bruker Corporation 2.56%
Sarepta Therapeutics, Inc. 2.36%
Dreyfus Government Cash Management (Institutional Shares) 0.04%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.